News
Virbac and SymbioCellTech Sign Exclusive Option Agreement to Develop Novel Technology for Treatment of Type 1 Diabetes in Companion Animals ACCESS Newswire Tue, Jan 12, 2021, 11:00 AM 4 min read ...
French drugmaker Virbac said Monday it would pick up two products marketed by Novartis Animal Health in the U.S.--the parasiticides Sentinel Flavor Tabs and Sentinel Spectrum--which Eli Lilly has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results